At Boehringer Ingelheim the bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. In line with our research-supporting initiatives we also sponsor and support scientific research conducted by external scientists active in our core indication areas.